Alanongy IV infusion 250mg

Alanongy IV infusion 250mg, manufactured by Sand Pharma, contains Nelarabine, with YJ code 4229402A1028 and a standard of 250mg 50mL 1 bottle. Nelarabine is an antineoplastic agent used for the treatment of T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL) in patients who have not responded to or have relapsed after prior therapies.